Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease
Conditions
Interventions
epoetin
methoxy polyethylene glycol-epoetin beta [Mircera]
Locations
59
United States
Davis, California, United States
Lakewood, Colorado, United States
Atlanta, Georgia, United States
Augusta, Georgia, United States
New Orleans, Louisiana, United States
Boston, Massachusetts, United States
Start Date
February 1, 2004
Primary Completion Date
June 1, 2006
Completion Date
June 1, 2006
Last Updated
November 2, 2016
NCT05012111
NCT03520647
NCT05447442
NCT06287268
NCT04645199
NCT03050268
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions